Literature DB >> 24155539

Low level laser therapy on experimental myopathy.

Soledad Dávila1, María Belén Vignola, David Cremonezzi, Juan C Simes, Fernando Soriano, Vilma R Campana.   

Abstract

PURPOSE: The aim of the present work was to study the effect of Helium-Neon (HeNe) and Gallium Arsenide (GaAs) laser upon nitric oxide (NO) plasma levels, an inflammatory biomarker associated with oxidative stress, in rats with experimental myopathy. These were evaluated through histological assessment.
MATERIALS AND METHODS: The groups studied were: (A) control (intact rats that received LLLT sham exposures), (B) rats with myopathy and sacrificed at 24 h later, (C) rats with myopathy and sacrificed 8 days later, (D) rats with myopathy and treated with HeNe laser, (E) rats with myopathy and treated with GaAs laser, (F) intact rats treated with HeNe laser and (G) intact rats treated with GaAs laser. Myopathy was induced by injecting 50μl of 1% carrageenan λ (type IV) in the left gastrocnemius muscle. Low Level Laser Therapy (LLLT) was applied with 9.5 J.cm(-2) daily for 10 consecutive days with each laser. The determination of the NO was made by spectrophotometry. The muscles were stained with Hematoxylin-Eosin and examined by optic microscopy. Quantitative variables were statistically analyzed by the Fisher test, and categorical by applying Pearson's Chi Squared test at p <0.05 for all cases.
RESULTS: In groups B and C, NO was significantly increased compared to groups A, D, E, F and G (p<0.05). In group C, the percentage of area with inflammatory infiltration was significantly increased compared to the other groups (p<0.001).
CONCLUSIONS: LLLT decreased plasma levels of NO in rats with experimental myopathies and significant muscle recovery.

Entities:  

Keywords:  Gallium Arsenide; Helium Neon; LLLT; myopathy; nitric oxide

Year:  2011        PMID: 24155539      PMCID: PMC3799039          DOI: 10.5978/islsm.11-or-02

Source DB:  PubMed          Journal:  Laser Ther        ISSN: 0898-5901


  29 in total

Review 1.  Muscle stem cells.

Authors:  Kirstin Goldring; Terence Partridge; Diana Watt
Journal:  J Pathol       Date:  2002-07       Impact factor: 7.996

2.  Inflammatory and oxidative stress markers in experimental crystalopathy: their modification by photostimulation.

Authors:  Claudia Reinoso Rubio; Juan Carlos Simes; Monica Moya; Fernando Soriano; Jose Atilio Palma; Vilma Campana
Journal:  Photomed Laser Surg       Date:  2009-02       Impact factor: 2.796

3.  [The use of the laser beam in therapy].

Authors:  E Mester
Journal:  Orv Hetil       Date:  1966-05-29       Impact factor: 0.540

4.  Laser therapy on arthritis induced by urate crystals.

Authors:  Vilma R Campana; Mónica Moya; Antonio Gavotto; Luis Spitale; Fernando Soriano; José A Palma
Journal:  Photomed Laser Surg       Date:  2004-12       Impact factor: 2.796

5.  Photobiomodulation of pain and inflammation in microcrystalline arthropathies: experimental and clinical results.

Authors:  F Soriano; V Campana; M Moya; A Gavotto; J Simes; M Soriano; R Soriano; L Spitale; J Palma
Journal:  Photomed Laser Surg       Date:  2006-04       Impact factor: 2.796

6.  Evaluation of inflammatory biomarkers associated with oxidative stress and histological assessment of low-level laser therapy in experimental myopathy.

Authors:  Natalia Servetto; David Cremonezzi; Juan C Simes; Monica Moya; Fernando Soriano; Jose A Palma; Vilma R Campana
Journal:  Lasers Surg Med       Date:  2010-08       Impact factor: 4.025

7.  Efficacy of different therapy regimes of low-power laser in painful osteoarthritis of the knee: a double-blind and randomized-controlled trial.

Authors:  Ali Gur; Abdulkadir Cosut; Aysegul Jale Sarac; Remzi Cevik; Kemal Nas; Asur Uyar
Journal:  Lasers Surg Med       Date:  2003       Impact factor: 4.025

8.  Cytokine mRNA expression is decreased in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low-level laser therapy.

Authors:  Regiane Albertini; Antonio Balbin Villaverde; Flavio Aimbire; Jan Bjordal; Aldo Brugnera; Josane Mittmann; Jose Antonio Silva; Maricilia Costa
Journal:  Photomed Laser Surg       Date:  2008-02       Impact factor: 2.796

9.  Low-energy laser irradiation promotes the survival and cell cycle entry of skeletal muscle satellite cells.

Authors:  Gavriella Shefer; Terry A Partridge; Louise Heslop; Jacqueline G Gross; Uri Oron; Orna Halevy
Journal:  J Cell Sci       Date:  2002-04-01       Impact factor: 5.285

10.  Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function.

Authors:  Kazuo Yudoh; van Trieu Nguyen; Hiroshi Nakamura; Kayo Hongo-Masuko; Tomohiro Kato; Kusuki Nishioka
Journal:  Arthritis Res Ther       Date:  2005-01-26       Impact factor: 5.156

View more
  3 in total

1.  Increase in the nitric oxide release without changes in cell viability of macrophages after laser therapy with 660 and 808 nm lasers.

Authors:  Igor Henrique Morais Silva; Samantha Cardoso de Andrade; Andreza Barkokebas Santos de Faria; Deborah Daniela Diniz Fonsêca; Luiz Alcino Monteiro Gueiros; Alessandra Albuquerque Tavares Carvalho; Wylla Tatiana Ferreira da Silva; Raul Manhães de Castro; Jair Carneiro Leão
Journal:  Lasers Med Sci       Date:  2016-09-16       Impact factor: 3.161

2.  Histomorphologic and ultrastructural recovery of myopathy in rats treated with low-level laser therapy.

Authors:  Natalia Servetto; David Cremonezzi; Juan Carlos Simes; Antonio Di Pietro; Vilma R Campana
Journal:  Lasers Med Sci       Date:  2017-03-09       Impact factor: 3.161

Review 3.  Effects of Photobiomodulation Therapy on Oxidative Stress in Muscle Injury Animal Models: A Systematic Review.

Authors:  Solange Almeida Dos Santos; Andrey Jorge Serra; Tatiane Garcia Stancker; Maíra Cecília Brandão Simões; Marcia Ataíze Dos Santos Vieira; Ernesto Cesar Leal-Junior; Marko Prokic; Andrea Vasconsuelo; Simone Silva Santos; Paulo de Tarso Camillo de Carvalho
Journal:  Oxid Med Cell Longev       Date:  2017-09-17       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.